Yahoo Finance

BrainXell, Inc. Appoints Katherine Vega Stultz as Chief Executive Officer and Board Director

MADISON, Wis., July 10, 2025 /PRNewswire/ -- BrainXell, Inc., a leading biotechnology company developing iPSC-based CNS disease models and regenerative cell therapies, announces the appointment of ...
Yahoo Finance

BrainXell Showcases Pioneering iPSC Research and Promising In Vivo Data for BXT-110 for Parkinson's Disease at the 2025 Society for Neuroscience Annual Meeting

SAN DIEGO, Nov. 15, 2025 /PRNewswire/ -- BrainXell, Inc. today announced that data will be presented during poster sessions at the 2025 Society for Neuroscience (SfN) Annual Meeting in San Diego, ...
Labroots

Advancing Neuroinflammation Research with iPSC-Derived Microglia and Automated Assays for Drug Discovery

Are current neuroinflammation models constraining your research? Traditional animal-derived cell assays lack the complexity of human microglia, limiting their predictive value and impeding progress in ...
Yahoo Finance

BrainXell Launches Human iPSC-Derived Sensory Neurons for Translational Neuroscience and Pain Biology Research

MADISON, Wis., March 4, 2026 /PRNewswire/ -- BrainXell today announced the launch of its human induced pluripotent stem cell (iPSC)-derived sensory neurons, a scalable human cellular platform ...
Fox2Now St. Louis

BrainXell Therapeutics Unveils Promising Preclinical Data Demonstrating Efficacy of BXT-110, an Autologous iPSC-Derived Neuronal Therapy, in Parkinson's Disease

SAN DIEGO, Nov. 3, 2025 /PRNewswire/ -- BrainXell Therapeutics today announced the disclosure of its first scientific data, which will be presented at two conferences this month: the Cell Symposia | ...